Shree Ganesh Biotech (India) Ltd
- Market cap
- ₹ 18 Cr.
- P/E
- 62.6x
- P/B
- 0.28x
- 52-week range
- 0.44 – 0.75
- ROE
- 1%
- ROCE
- 0.8%
- Dividend yield
- 0%
- Debt / equity
- 0
- Sector
- Pharmaceuticals & Biotechnology
- Industry
- Biotechnology
- Listed on
- BSE
About
Shree Ganesh Bio-Tech (India) Limited is an India-based company. The Company is engaged in the business of production, processing and marketing of hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum and various others.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Biotechnology: 6 companies →Shree Ganesh Biotech (India) Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)62.6 against a typical 64.5: cheaper than most peers (1st = cheapest).3rd of 6
- Sales growth+3.6% against a typical +2.2% from a year earlier.2nd of 5
- Profit growth−272.7% against a typical −50% from a year earlier.5th of 5
- Share price, 3 months−13.2% against a typical −13.2%.3rd of 5
- Size₹ 17.9 Cr. market value against a typical ₹ 82.4 Cr. (1st = largest).5th of 6
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4 | 4 | 4 | 4 | 2 | 14 | 3 | 1 | 1 | 1 | 2 | 1 |
| Expenses | 4 | 4 | 4 | 4 | 2 | 14 | 4 | 1 | 1 | 1 | 3 | 2 |
| Operating Profit | 0 | 0 | −1 | −0 | 0 | 0 | −1 | −0 | −0 | −0 | −0 | −1 |
| OPM % | 1.9% | 2.2% | −13.8% | −3.7% | 1% | 3.3% | −47.2% | −6.5% | −52% | −7.1% | −20.3% | −62.2% |
| Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 1 | 0 | 0 | 1 | −1 | 0 | 0 | 0 | −0 | −1 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 0 | 0 | 1 | 0 | 0 | 1 | −1 | 0 | 0 | 0 | −0 | −1 |
| EPS in Rs | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.02 | −0.02 | 0.01 | 0 | 0.01 | 0 | −0.01 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 9%
- 5 Years
- −22%
- 3 Years
- −57%
- TTM
- −76%
- 10 Years
- −3%
- 5 Years
- −6%
- 3 Years
- −43%
- TTM
- −183%
- 10 Years
- —
- 5 Years
- −41%
- 3 Years
- −21%
- TTM
- —
- 10 Years
- 3%
- 5 Years
- 2%
- 3 Years
- 1%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Shree Ganesh Biotech (India) Ltd | ₹ 0.46 | ₹ 18 Cr. | 62.6x | 0.3x | 1% | — |
| Kaveri Seed Company | ₹ 731.00 | ₹ 3,752 Cr. | 14.8x | 2.5x | 18.2% | 21.2% |
| Andrew Yule & Company Ltd | ₹ 21.85 | ₹ 1,081 Cr. | — | 3.7x | −5.8% | −10.5% |
| Bombay Super Hybrid Seeds | ₹ 82.90 | ₹ 870 Cr. | 35x | 7.1x | 22.6% | 7.5% |
| Fratelli Vineyards | ₹ 123.50 | ₹ 537 Cr. | — | 3.2x | −17.1% | −13.7% |
| Harrisons Malayalam | ₹ 156.75 | ₹ 291 Cr. | 13.9x | 2.3x | 17.5% | 5.4% |
Management
- Aman Patel
- Whole-time Chairman of the Board
- Kishan Nityanand Naidu
- Chief Financial Officer, Non-Executive Director
- Namita Acharya
- Company Secretary
Prices are delayed and for information only. Nothing on this page is investment advice.